Despite how many women are affected by chronic pelvic pain, we still don’t fully understand the mechanisms underlying it—thereby limiting treatment options.
Researchers examined a random sample of health insurance claim records of 16 million patients in the United States between 2006 and 2020 for use of semaglutide drugs.
